サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1786631

消化管ドラッグデリバリーシステムアウトソーシングの世界市場

Gastroretentive Drug Delivery Systems Outsourcing

出版日
ページ情報
英文 188 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
消化管ドラッグデリバリーシステムアウトソーシングの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 188 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

消化管ドラッグデリバリーシステムアウトソーシングの世界市場は2030年までに20億米ドルに到達

2024年に15億米ドルと推定される消化管ドラッグデリバリーシステムアウトソーシングの世界市場は、2024年から2030年にかけてCAGR 5.2%で成長し、2030年には20億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである錠剤剤形は、CAGR 3.8%を記録し、分析期間終了時には6億1,700万米ドルに達すると予測されます。液体剤形セグメントの成長率は、分析期間中CAGR 6.9%と推定されます。

米国市場は4億250万米ドルと推定、中国はCAGR 8.0％で成長すると予測

米国の消化管ドラッグデリバリーシステムアウトソーシング市場は2024年に4億250万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年にかけてCAGR 8.0%で推移し、2030年には3億9,420万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.6%と5.1%と予測されています。欧州では、ドイツがCAGR 3.3%で成長すると予測されています。

世界の消化管ドラッグデリバリーシステムアウトソーシング市場- 主要動向と促進要因まとめ

吸収窓が狭い、あるいは上部消化管（GI）での溶解度が限られている薬剤のバイオアベイラビリティと治療効果の改善を製薬企業が求める中、胃内滞留性ドラッグデリバリーシステム（GRDDS）のアウトソーシングが大きな注目を集めています。浮遊システム、生体接着システム、膨潤・膨張システム、高密度システムなどのGRDDS技術は高度に専門化されており、製剤化に関する広範な専門知識と高度なインフラを必要とします。そのため、多くの医薬品開発企業は、これらの複雑な製剤を効率的に市場に投入するための技術力と規制上のノウハウを有する開発・製造受託機関（CDMO）と提携しています。

GRDDSアウトソーシング市場に影響を与える主な動向には、徐放性経口製剤に対する需要の高まり、患者中心のドラッグデリバリーへの注目の高まり、競合情勢の中で製品を差別化する必要性などがあります。GRDDSの採用は、薬物滞留時間の延長が治療効果を高める慢性胃腸障害、心血管疾患、2型糖尿病の治療薬に特に価値があります。大手製薬企業が中核となる研究開発に集中するために社内業務を合理化する中、GRDDSの製剤化、スケールアップ、製造といった非中核業務のアウトソーシングは戦略上不可欠となっています。さらに、薬物放出プロファイルの一貫性に対する規制当局の期待や、ライフサイクル管理の重視の高まりも、この分野における専門パートナーの必要性を高めています。

GRDDSが技術的に要求され、アウトソーシングする魅力があるのはなぜか？

胃内滞留性ドラッグデリバリーシステムは本質的に複雑であり、胃内での薬物放出速度論、浮力、粘着性、膨張を正確に制御しなければならない高度な技術を伴います。このような要件は、製剤設計、賦形剤の選択、リアルタイムのin vitro/in vivo相関試験などに大きな需要をもたらします。中小規模の製薬会社では、特に初期段階の開発において、このようなシステムを独自に開発するための社内インフラが不足していることが多いです。アウトソーシングを利用することで、高度な分析ツール、GRDDSに特化した賦形剤ライブラリー、パイロットスケールの生産設備を資本負担なく利用することができます。

もう一つの大きな要因は、ポリマーサイエンスへの関心が高まっていることで、胃内滞留性や薬物吸収性を改善するために、新規の生体接着性ポリマーやハイドロゲルが開発されています。材料科学と放出制御プラットフォームの専門知識を持つCDMOは、GRDDS対応医薬品の市場投入までの時間を短縮する上で、今や重要な協力者となっています。その他の特典として、腸内で分解されることが多く、上部消化管吸収の恩恵を受ける経口生物製剤やペプチドの需要が増加しているため、製剤メーカーはGRDDSルートを求めるようになっています。このようなニッチな能力は、多くの製薬企業にとって社内で利用できることは稀であり、アウトソーシング・パートナーは、このような新たな製剤課題に取り組む上で重要なイネーブラーとして位置づけられています。

需要を形成している治療分野と最終用途動向は？

GRDDSの治療用途は、胃腸の健康という従来の重点分野を超えて拡大しています。消化性潰瘍、ヘリコバクター・ピロリ除菌、胃食道逆流症（GERD）が依然として主な用途である一方、胃の部位特異的ドラッグデリバリーを必要とする代謝性疾患、パーキンソン病、感染症の管理におけるGRDDSの用途が著しく増加しています。pHに依存する溶解性や腸液中での安定性が低い薬剤は特にGRDDSに適しており、このアプローチは再製剤戦略や既存分子のライフサイクル延長にとって魅力的なものとなっています。

アウトソーシングの需要は、高齢化社会への対応と患者のアドヒアランスの向上を目指す製薬会社によっても牽引されています。GRDDS技術により、投与回数の削減と薬物動態プロファイルの向上が可能になり、これは慢性治療に不可欠です。小児および高齢者向けのドラッグデリバリーでは、浮遊性および粘接着性のGRDDSが薬物放出と滞留時間の制御を改善し、嚥下性や投与量の均一性に関する懸念に対処します。使いやすい経口剤形と、これらの特定の集団に対する規制上の書類作成サポートに強い背景を持つ主要企業が、開発プロジェクトを主導するために積極的に求められています。

世界のGRDDSアウトソーシングの成長の原動力は？

消化管ドラッグデリバリーシステムアウトソーシング市場の成長は、上部消化管への標的送達を必要とする薬剤分子の複雑化、慢性胃疾患や代謝性疾患の有病率の増加、バイオアベイラビリティの向上が有効な薬剤のパイプラインの増加など、いくつかの要因によって牽引されています。ライフサイクル管理や合剤への関心の高まりなど、進化する医薬品研究開発の状況は、GRDDS技術にとって肥沃な土壌となっています。アウトソーシングにより、企業はCDMOが提供する専門的な知識ベース、独自の送達プラットフォーム、迅速なスケールアッププロセスを利用することができます。

スマートポリマー、浮遊製剤用ガス発生システム、胃内滞留性錠剤の高度な3Dプリンティングなどの技術革新は、外部委託開発パートナーの能力をさらに高めています。さらに、GRDDS対応製品に関する規制の明確化や、Quality-by-Design（QbD）の世界の重視は、専門的なアウトソーシング・プロバイダーとの早期連携を促しています。インドや東欧のような新興市場におけるCDMOサービスの拡大も、科学的専門性の高まりによってコスト面での優位性が補完され、アウトソーシング動向に拍車をかけています。製薬企業が製品開発において俊敏性、革新性、スピードを求め続ける中、GRDDSのアウトソーシングは医薬品開発のバリューチェーン全体において戦略的重点分野であり続けるでしょう。

セグメント

剤形（錠剤剤形、液剤剤形、マイクロスフェア剤形、カプセル剤形、その他の剤形）

調査対象企業の例

  • Adare Pharma Solutions
  • Aenova Group
  • Almac Group
  • Aptar Pharma
  • Ashland Global Holdings Inc.
  • Catalent, Inc.
  • Colorcon, Inc.
  • Convatec Group
  • CordenPharma International
  • Evonik Industries AG
  • Evotec SE
  • Halozyme Therapeutics
  • Lonza Group AG
  • Patheon（Thermo Fisher Scientific）
  • Pharmaron Beijing Co., Ltd.
  • Quotient Sciences
  • Recipharm AB
  • Rubicon Research Pvt. Ltd.
  • Siegfried Holding AG
  • Vectura Group Ltd.

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP31156

Global Gastroretentive Drug Delivery Systems Outsourcing Market to Reach US$2.0 Billion by 2030

The global market for Gastroretentive Drug Delivery Systems Outsourcing estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Tablets Dosage Form, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$617.0 Million by the end of the analysis period. Growth in the Liquid Dosage Form segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$402.5 Million While China is Forecast to Grow at 8.0% CAGR

The Gastroretentive Drug Delivery Systems Outsourcing market in the U.S. is estimated at US$402.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$394.2 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Gastroretentive Drug Delivery Systems Outsourcing Market - Key Trends & Drivers Summarized

The outsourcing of gastroretentive drug delivery systems (GRDDS) is gaining significant traction as pharmaceutical companies seek to improve bioavailability and therapeutic efficacy of drugs with narrow absorption windows or limited solubility in the upper gastrointestinal (GI) tract. GRDDS technologies such as floating systems, bioadhesive systems, swelling and expanding systems, and high-density systems are highly specialized and require extensive formulation expertise and advanced infrastructure. As a result, many drug developers are partnering with contract development and manufacturing organizations (CDMOs) that possess the technical capabilities and regulatory know-how to bring these complex formulations to market efficiently.

Key trends influencing the GRDDS outsourcing market include rising demand for extended-release oral formulations, increasing focus on patient-centric drug delivery, and the need to differentiate products in a competitive therapeutic landscape. The adoption of GRDDS is particularly valuable for drugs treating chronic gastrointestinal disorders, cardiovascular diseases, and type 2 diabetes, where prolonged drug residence time enhances therapeutic outcomes. As major pharmaceutical firms streamline internal operations to focus on core R&D, outsourcing non-core competencies such as GRDDS formulation, scale-up, and manufacturing has become a strategic imperative. Furthermore, regulatory expectations for consistency in drug release profiles and the growing emphasis on lifecycle management are also driving the need for specialized partners in this space.

What Makes GRDDS So Technically Demanding - And Attractive to Outsource?

Gastroretentive drug delivery systems are inherently complex, involving advanced technologies that must ensure precise control over drug release kinetics, buoyancy, adhesion, or expansion in the stomach. These requirements place significant demands on formulation design, choice of excipients, and real-time in vitro/in vivo correlation testing. Small and mid-sized pharmaceutical companies often lack the in-house infrastructure to develop such systems independently, especially for early-phase development. Outsourcing allows them access to advanced analytical tools, GRDDS-specific excipient libraries, and pilot-scale production facilities without the capital burden.

Another major factor is the growing interest in polymer science, where novel bioadhesive polymers and hydrogels are being developed to improve gastric retention and drug absorption. CDMOs with expertise in material science and controlled-release platforms are now critical collaborators in accelerating time-to-market for GRDDS-enabled drugs. Additionally, the increasing demand for oral biologics and peptides, which often degrade in the intestines and benefit from upper GI absorption, is pushing formulators to seek GRDDS routes. This niche capability is rarely available in-house for many pharmaceutical firms, positioning outsourcing partners as key enablers in addressing these emerging formulation challenges.

Which Therapeutic Areas and End-Use Trends Are Shaping the Demand?

Therapeutic applications of GRDDS are expanding beyond the traditional focus areas of gastrointestinal health. While peptic ulcers, Helicobacter pylori eradication, and gastroesophageal reflux disease (GERD) still dominate usage, there is a marked rise in the application of GRDDS in the management of metabolic disorders, Parkinson’s disease, and infectious diseases requiring site-specific drug delivery in the stomach. Drugs with pH-dependent solubility or poor stability in intestinal fluids are particularly well-suited to GRDDS, making this approach attractive for reformulation strategies and lifecycle extension of existing molecules.

Outsourcing demand is also being driven by pharmaceutical companies aiming to serve aging populations and improve patient adherence. GRDDS technologies enable reduced dosing frequency and enhanced pharmacokinetic profiles, which are essential in chronic therapies. In pediatric and geriatric drug delivery, floating and mucoadhesive GRDDS offer better control over drug release and residence time, addressing swallowability and dose uniformity concerns. Outsourcing companies with a strong background in user-friendly oral dosage forms and regulatory dossier support for these specific populations are being actively sought out to lead development projects.

What’s Fueling the Growth in GRDDS Outsourcing Across the Globe?

The growth in the gastroretentive drug delivery systems outsourcing market is driven by several factors, including the rising complexity of drug molecules requiring targeted delivery in the upper GI tract, the increasing prevalence of chronic gastric and metabolic diseases, and a growing pipeline of drugs that benefit from enhanced bioavailability. The evolving pharmaceutical R&D landscape-with heightened focus on lifecycle management and fixed-dose combinations-has created a fertile ground for GRDDS technologies. Outsourcing enables companies to tap into specialized knowledge bases, proprietary delivery platforms, and faster scale-up processes offered by CDMOs.

Technological innovations such as smart polymers, gas-generating systems for floating formulations, and advanced 3D printing of gastroretentive tablets are further enhancing the capabilities of outsourced development partners. Additionally, regulatory clarity around GRDDS-enabled products and a strong global emphasis on quality-by-design (QbD) are encouraging early engagement with expert outsourcing providers. The expansion of CDMO services in emerging markets like India and Eastern Europe-where cost advantages are complemented by growing scientific expertise-is also fueling the outsourcing trend. As pharmaceutical companies continue to seek agility, innovation, and speed in product development, GRDDS outsourcing is set to remain a strategic focus area across the drug development value chain.

SCOPE OF STUDY:

The report analyzes the Gastroretentive Drug Delivery Systems Outsourcing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Dosage Form (Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form, Other Dosage Forms)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Adare Pharma Solutions
  • Aenova Group
  • Almac Group
  • Aptar Pharma
  • Ashland Global Holdings Inc.
  • Catalent, Inc.
  • Colorcon, Inc.
  • Convatec Group
  • CordenPharma International
  • Evonik Industries AG
  • Evotec SE
  • Halozyme Therapeutics
  • Lonza Group AG
  • Patheon (Thermo Fisher Scientific)
  • Pharmaron Beijing Co., Ltd.
  • Quotient Sciences
  • Recipharm AB
  • Rubicon Research Pvt. Ltd.
  • Siegfried Holding AG
  • Vectura Group Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Gastroretentive Drug Delivery Systems Outsourcing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Complexity of GRDDS Formulations Spurs Demand for Specialized Outsourcing Partners
    • Pharma Industry Focus on Core R&D and Cost Reduction Accelerates Outsourcing of Gastroretentive Drug Development
    • Growing Number of Emerging Biopharma and Virtual Drug Companies Increases Outsourcing Demand for GRDDS
    • CMOs and CDMOs Expanding Capabilities in Mucoadhesive, Floating, and Swellable GRDDS Boost Outsourcing Opportunities
    • Need for Specialized Equipment and Regulatory Expertise Drives Contract Manufacturing of GRDDS Technologies
    • OEM Investments in Dedicated Oral Solid Dosage Lines Enhance Service Offering for Gastroretentive Formulations
    • Growth in Modified Release and Site-Specific Delivery Markets Creates Outsourcing Opportunities for Niche CDMOs
    • Increased FDA and EMA Regulatory Stringency Spurs Demand for GRDDS Outsourcing to Compliant Facilities
    • Collaborative GRDDS Development Models Between Innovators and CMOs Strengthen Speed-to-Market Advantage
    • Focus on Small Batch, High-Potency Drug Formulation Supports Outsourcing of Clinical-Stage GRDDS Projects
    • Rising Demand for Analytical and Bioavailability Testing Capabilities Expands Scope of GRDDS Outsourcing
    • Contract Development Partners Offering 3D Printing and Novel Dosage Platforms Gain Competitive Edge in GRDDS Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gastroretentive Drug Delivery Systems Outsourcing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Tablets Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Tablets Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Tablets Dosage Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Liquid Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Liquid Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Liquid Dosage Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Microspheres Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Microspheres Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Microspheres Dosage Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Capsule Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Capsule Dosage Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Capsule Dosage Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • JAPAN
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Japan 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • CHINA
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 29: China Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: China Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: China 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • EUROPE
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • FRANCE
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 38: France Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: France Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: France 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • GERMANY
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 41: Germany Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Germany Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Germany 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 44: Italy Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Italy Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Italy 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 47: UK Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: UK Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: UK 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 50: Spain Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Spain Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Spain 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 53: Russia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Russia Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Russia 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Rest of Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 65: Australia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Australia Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Australia 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • INDIA
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 68: India Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: India Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: India 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 71: South Korea Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: South Korea Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: South Korea 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Rest of Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 80: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Latin America Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 83: Argentina Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Argentina Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Argentina 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 86: Brazil Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Brazil Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Brazil 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 89: Mexico Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Mexico Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Mexico 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Latin America Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 98: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Middle East Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 101: Iran Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Iran Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Iran 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 104: Israel Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Israel Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Israel 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Saudi Arabia Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Saudi Arabia 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 110: UAE Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UAE Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UAE 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Middle East Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Rest of Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030
  • AFRICA
    • Gastroretentive Drug Delivery Systems Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 116: Africa Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Africa Historic Review for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Africa 15-Year Perspective for Gastroretentive Drug Delivery Systems Outsourcing by Dosage Form - Percentage Breakdown of Value Sales for Tablets Dosage Form, Liquid Dosage Form, Microspheres Dosage Form, Capsule Dosage Form and Other Dosage Forms for the Years 2015, 2025 & 2030

IV. COMPETITION